Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1533133rdf:typepubmed:Citationlld:pubmed
pubmed-article:1533133lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0079722lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0487602lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0205173lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0079603lld:lifeskim
pubmed-article:1533133lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:1533133pubmed:issue2lld:pubmed
pubmed-article:1533133pubmed:dateCreated1992-5-26lld:pubmed
pubmed-article:1533133pubmed:abstractTextThree cases of malignant lymphoma were examined immunohistochemically using anti-Leu monoclonal antibodies (MAB) against B lymphocytes, T lymphocytes subsets, NK cells, IL-2 receptor. In all three cases tumor cells were stained with anti-B cell's MABs, that is they were diagnosed as B cell type of malignant lymphoma. Moderate tumor-infiltrating lymphocytes in the parenchyma or around blood vessels were observed, and majority of these cells were T lymphocytes, demonstrating Leu 2a or Leu 3a + 3b positive phenotypes. IL-2 receptor positive cells also found in the parenchyma of these tumors. T lymphocyte subsets, such as Leu 2a positive cells and Leu 3a + 3b positive cells, were analyzed by means of double immunofluorescence staining method using the combination of Leu 2a and Leu15, or Leu 3a + 3b and Leu 8 MABs. This method demonstrated that most of Leu 2a positive cells were negative for Leu 15 and that the majority of Leu 3a + 3b positive cells were negative for Leu 8. These results suggested that tumor-infiltrating lymphocytes in the malignant lymphoma were mainly activated cytotoxic or helper T cells.lld:pubmed
pubmed-article:1533133pubmed:languagejpnlld:pubmed
pubmed-article:1533133pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1533133pubmed:citationSubsetIMlld:pubmed
pubmed-article:1533133pubmed:statusMEDLINElld:pubmed
pubmed-article:1533133pubmed:monthFeblld:pubmed
pubmed-article:1533133pubmed:issn0006-8969lld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:ShigematsuHHlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:MatsumotoKKlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:OhmotoTTlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:NishimotoAAlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:TsunoKKlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:FurutaTTlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:MishimaNNlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:MaeshiroTTlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:MatsuhisaTTlld:pubmed
pubmed-article:1533133pubmed:authorpubmed-author:KunishioKKlld:pubmed
pubmed-article:1533133pubmed:issnTypePrintlld:pubmed
pubmed-article:1533133pubmed:volume44lld:pubmed
pubmed-article:1533133pubmed:ownerNLMlld:pubmed
pubmed-article:1533133pubmed:authorsCompleteYlld:pubmed
pubmed-article:1533133pubmed:pagination125-30lld:pubmed
pubmed-article:1533133pubmed:dateRevised2007-2-22lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:meshHeadingpubmed-meshheading:1533133-...lld:pubmed
pubmed-article:1533133pubmed:year1992lld:pubmed
pubmed-article:1533133pubmed:articleTitle[Analysis of tumor-infiltrating lymphocyte in primary malignant lymphoma of the central nervous system using double immunofluorescence staining method].lld:pubmed
pubmed-article:1533133pubmed:affiliationDepartment of Neurological Surgery, Okayama University Medical School, Japan.lld:pubmed
pubmed-article:1533133pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1533133pubmed:publicationTypeEnglish Abstractlld:pubmed